We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

132 hedge funds and large institutions have $570M invested in Emergent Biosolutions in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 49 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

26% more capital invested

Capital invested by funds: $451M → $570M (+$119M)

10% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 49

5% more funds holding

Funds holding: 126 → 132 (+6)

2.93% more ownership

Funds ownership: 66.34% → 69.27% (+2.9%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
132
Holders Change
+6
Holders Change %
+4.76%
% of All Funds
3.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
17
Increased
54
Reduced
49
Closed
11
Calls
$597K
Puts
–
Net Calls
+$597K
Net Calls Change
+$561K

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$4.67M
2
BA
BlackRock Advisors
Delaware
+$4.41M
3
Morgan Stanley
Morgan Stanley
New York
+$2.77M
4
Charles Schwab
Charles Schwab
California
+$2.43M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.08M

Top Sellers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
-$4.92M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.9M
3
RFC
Russell Frank Company
Washington
-$1.48M
4
State Street
State Street
Massachusetts
-$1.05M
5
KIA
King Investment Advisors
Texas
-$1.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$4.36M -$54.2K -2,600 -1%
Wellington Management Group
27
Wellington Management Group
Massachusetts
$4.35M +$655K +31,400 +20%
SBH
28
Segall Bryant & Hamill
Illinois
$4.27M -$117K -5,595 -3%
TCIM
29
TIAA CREF Investment Management
New York
$4.17M -$149K -7,131 -4%
Principal Financial Group
30
Principal Financial Group
Iowa
$4.06M +$174K +8,348 +5%
CCMH
31
Cornerstone Capital Management Holdings
New York
$3.7M -$944K -45,300 -22%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$3.62M +$241K +11,565 +8%
CRC
33
Curi RMB Capital
Illinois
$3.09M +$867K +41,578 +45%
Morgan Stanley
34
Morgan Stanley
New York
$3.06M +$2.77M +133,026 New
GC
35
Guggenheim Capital
Illinois
$2.98M -$5.71K -274 -0.2%
MOACM
36
Mutual of America Capital Management
New York
$2.94M +$806K +38,667 +43%
AI
37
Ariel Investments
Illinois
$2.82M +$1.31M +63,050 +106%
ERSOT
38
Employees Retirement System of Texas
Texas
$2.64M +$208K +10,000 +10%
Ameriprise
39
Ameriprise
Minnesota
$2.62M +$83.1K +3,985 +4%
Millennium Management
40
Millennium Management
New York
$2.58M -$532K -25,509 -19%
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
$2.48M -$228K -10,937 -9%
BIM
42
BlackRock Investment Management
Delaware
$2.42M -$35K -1,680 -2%
OAM
43
Oxford Asset Management
United Kingdom
$2.41M +$1.37M +65,483 +166%
RFC
44
Russell Frank Company
Washington
$2.21M -$1.48M -70,807 -43%
Deutsche Bank
45
Deutsche Bank
Germany
$2.21M -$570K -27,336 -22%
CS
46
Credit Suisse
Switzerland
$2.21M +$1.11M +53,207 +124%
Two Sigma Investments
47
Two Sigma Investments
New York
$2M +$938K +44,966 +107%
TC
48
TFS Capital
Pennsylvania
$2M -$558K -26,747 -24%
PPA
49
Parametric Portfolio Associates
Washington
$1.82M +$287K +13,773 +21%
MCM
50
Matarin Capital Management
New York
$1.76M +$752K +36,071 +89%
1
2
3 4 5

EBS Hedge Fund Activity: Q4 2013 in Review

132 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q4 2013, worth a combined $570M — up 26% from $451M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new EBS positions and 11 closed out — a net gain of 6 holders — while 54 added to existing stakes and 49 trimmed.

The largest buyer was Panagora Asset Management, opening a new position worth an estimated $4.67M. The largest seller was Kingdon Capital Management, cutting an estimated $4.92M.

  • 132 institutional investors held Emergent Biosolutions (EBS) as of Q4 2013, up from 126 in Q3 2013.
  • Funds reported $570M of Emergent Biosolutions stock for Q4 2013, up 26% quarter-over-quarter.
  • 17 funds opened new Emergent Biosolutions positions in Q4 2013 and 11 closed out, a net change of +6 holders.
  • The largest Emergent Biosolutions buyer in Q4 2013 was Panagora Asset Management, an estimated $4.67M added.
  • The largest Emergent Biosolutions seller in Q4 2013 was Kingdon Capital Management, an estimated $4.92M sold.

Based on aggregated 13F filings for Q4 2013.